SD

Sushmita Dubey

Active Director Director DIN 08396200
DIN 08396200 First appointment Mar 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Sushmita Dubey

Data last updated:

Sushmita Dubey is a Director at Airiza Pharmaceuticals Private Limited (since 2019). The company operates in Healthcare. Airiza Pharmaceuticals Private Limited reported revenue of ₹1.8 Lakh (FY 2022).

DIN 08396200
Primary Designation Director
Industry Healthcare
First Appointment 22 Mar 2019
Oldest Company Age 7 yrs
Largest company Airiza Pharmaceuticals Private Limited · ₹1.8 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20192019₹1.8 Lakh (FY 2022)Active

Board colleagues of Sushmita Dubey

NameDINCompanyDesignation
Goutam Dubey10968973Airiza Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Airiza Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushmita Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushmita Dubey

Sushmita Dubey currently holds 1 directorship: Airiza Pharmaceuticals Private Limited (Director, since 22 Mar 2019, revenue ₹1.8 Lakh (FY 2022)).

Sushmita Dubey was first appointed on 22 Mar 2019 as Director at Airiza Pharmaceuticals Private Limited.

The current boards of Sushmita Dubey's companies include Goutam Dubey (Airiza Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available